Correction: Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes.

Feist, Eugen; Baraliakos, Xenofon; Behrens, Frank; Thaçi, Diamant; Klopsch, Thilo; Plenske, Anja; Blindzellner, Lisa K; Klaus, Pascal; Meng, Thomas; Löschmann, Peter-Andreas

Feist, Eugen; Baraliakos, Xenofon; Behrens, Frank; Thaçi, Diamant; Klopsch, Thilo; Plenske, Anja; Blindzellner, Lisa K; Klaus, Pascal; Meng, Thomas; Löschmann, Peter-Andreas.

Afiliação

Feist E; Department of Rheumatology, Helios Fachklinik, Sophie-von-Boetticher-Straße 1, 39245, Vogelsang-Gommern, Germany. eugen.feist@helios-gesundheit.de.
Baraliakos X; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin, Berlin, Germany. eugen.feist@helios-gesundheit.de.
Behrens F; Otto-von-Guericke University, Magdeburg, Germany. eugen.feist@helios-gesundheit.de.
Thaçi D; Rheumatology Center Ruhrgebiet Herne, Ruhr-University, Bochum, Germany.
Klopsch T; CIRI/Rheumatology and Fraunhofer IME, Institute for Translational Medicine and Pharmacology, Goethe University Hospital, Frankfurt/Main, Germany.
Plenske A; Institute and Comprehensive Center Inflammation Medicine, University of Lübeck, Lübeck, Germany.
Blindzellner LK; Rheumatology Practice, Neubrandenburg, Germany.
Klaus P; Pfizer Pharma GmbH, Berlin, Germany.
Meng T; Pfizer Pharma GmbH, Berlin, Germany.
Löschmann PA; Pfizer Pharma GmbH, Berlin, Germany.

Rheumatol Ther ; 10(6): 1809-1810, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37668866

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Rheumatol Ther Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google